GSK to honor UK's MHRA recommendation on Seroxat

Published: 2003-06-17 06:56:00

Updated: 2003-06-17 06:56:00

Glaxo-SmithKline Korea said recently that in line with the June 10 recommendation of Medicine and Healthcare Products Regulatory Agency (MHRA) in U.K. that Seroxat (paroxetine) should not be prescribed to young depressed patients with less than 18 of age, it would accept such decision and the MHP...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK